inVentiv Health Inc.
Quarterly Segment Reporting Summary
Q1 2006 - Q2 2007
(unaudited)
(in millions) | ||||||
2006 Q1 | inVentiv | inVentiv | inVentiv | inVentiv | ||
Clinical | Commercial | Communications | Patient Outcomes | Corporate | Total | |
Revenue | $ 32.5 | $ 86.2 | $ 45.7 | $ 9.3 | $ - | $ 173.7 |
Adjusted Operating Income * | $ 1.6 | $ 13.1 | $ 7.6 | $ 0.5 | $ (2.3) | $ 20.5 |
Less: Stock Compensation Expense | 0.3 | 0.9 | 0.1 | 0.1 | 0.2 | 1.6 |
Reported Operating Income | $ 1.3 | $ 12.2 | $ 7.5 | $ 0.4 | $ (2.5) | $ 18.9 |
2006 Q2 | inVentiv | inVentiv | inVentiv | inVentiv | ||
Clinical | Commercial | Communications | Patient Outcomes | Corporate | Total | |
Revenue | $ 38.4 | $ 77.1 | $ 50.8 | $ 16.7 | $ - | $ 183.0 |
Adjusted Operating Income * | $ 3.9 | $ 11.7 | $ 6.6 | $ 2.1 | $ (2.4) | $ 21.9 |
Less: Stock Compensation Expense | 0.3 | 0.9 | 0.2 | 0.0 | 0.3 | 1.7 |
Reported Operating Income | $ 3.6 | $ 10.8 | $ 6.4 | $ 2.1 | $ (2.7) | $ 20.2 |
2006 Q3 | inVentiv | inVentiv | inVentiv | inVentiv | ||
Clinical | Commercial | Communications | Patient Outcomes | Corporate | Total | |
Revenue | $ 40.0 | $ 88.1 | $ 53.5 | $ 16.2 | $ - | $ 197.8 |
Adjusted Operating Income * | $ 4.2 | $ 10.8 | $ 8.9 | $ 1.7 | $ (2.9) | $ 22.7 |
Less: Stock Compensation Expense | 0.3 | 0.9 | 0.2 | 0.2 | 0.6 | 2.2 |
Reported Operating Income | $ 3.9 | $ 9.9 | $ 8.7 | $ 1.5 | $ (3.5) | $ 20.5 |
2006 Q4 | inVentiv | inVentiv | inVentiv | inVentiv | ||
Clinical | Commercial | Communications | Patient Outcomes | Corporate | Total | |
Revenue | $ 39.0 | $ 95.7 | $ 57.4 | $ 19.7 | $ - | $ 211.8 |
Adjusted Operating Income * | $ 3.1 | $ 13.5 | $ 7.3 | $ 3.4 | $ (3.3) | $ 24.0 |
Less: Stock Compensation Expense | 0.3 | 0.6 | 0.2 | 0.3 | 0.6 | 2.0 |
Adjusted Operating Income ** | $ 2.8 | $ 12.9 | $ 7.1 | $ 3.1 | $ (3.9) | $ 22.0 |
Less: Acquisition-related incentive | - | - | 3.5 | - | - | 3.5 |
Reported Operating Income | $ 2.8 | $ 12.9 | $ 3.6 | $ 3.1 | $ (3.9) | $ 18.5 |
2007 Q1 | inVentiv | inVentiv | inVentiv | inVentiv | ||
Clinical | Commercial | Communications | Patient Outcomes | Corporate | Total | |
Revenue | $ 41.4 | $ 97.8 | $ 61.4 | $ 21.4 | $ - | $ 222.0 |
Adjusted Operating Income * | $ 2.2 | $ 10.0 | $ 8.5 | $ 3.6 | $ (3.4) | $ 20.9 |
Less: Stock Compensation Expense | 0.4 | 1.1 | 0.3 | 0.0 | 0.6 | 2.4 |
Reported Operating Income | $ 1.8 | $ 8.9 | $ 8.2 | $ 3.6 | $ (4.0) | $ 18.5 |
2007 Q2 | inVentiv | inVentiv | inVentiv | inVentiv | ||
Clinical | Commercial | Communications | Patient Outcomes | Corporate | Total | |
Revenue | $ 47.0 | $ 97.8 | $ 65.9 | $ 21.7 | $ - | $ 232.4 |
Adjusted Operating Income * | $ 3.2 | $ 13.3 | $ 9.1 | $ 3.5 | $ (3.3) | $ 25.8 |
Less: Stock Compensation Expense | 0.4 | 1.1 | 0.3 | 0.1 | 0.6 | 2.5 |
Adjusted Operating Income ** | $ 2.8 | $ 12.2 | $ 8.8 | $ 3.4 | $ (3.9) | $ 23.3 |
Less: Receivable reserve | - | 8.2 | - | - | - | 8.2 |
Reported Operating Income | $ 2.8 | $ 4.0 | $ 8.8 | $ 3.4 | $ (3.9) | $ 15.1 |
* Excludes stock compensation expense, acquisition-related incentive and receivable reserve, where applicable. (See Form 8-K, Item 7.01 for further details) | ||||||
** Excludes acquisition-related incentive and receivable reserve as disclosed above for 2006 Q4 and 2007 Q2, respectively. (See Form 8-K, Item 7.01 for further details) |